Wash. Federal Judge Moves False Advertising Suit Against Semaglutide Seller Forward
SEATTLE — A Washington federal judge on Jan. 26 ruled that a false advertising and unfair competition case filed by the maker of semaglutide drugs can move forward, finding that the...To view the full article, register now.
Already a subscriber? Click here to view full article